Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» vaccines
vaccines
Pfizer CEO Bourla stung by UK's pharma marketing regulator over kids' COVID vax claims: report
Fierce Pharma
Mon, 11/28/22 - 10:14 am
Pfizer
COVID-19
vaccines
UK
Albert Bourla
Pharma CEOs
pharma marketing
regulatory
PMCPA
Experimental flu vaccine, developed using mRNA, seen as potential game changer
Stat
Sun, 11/27/22 - 07:10 pm
MRNA
vaccines
Flu
flu vaccines
FDA grants priority review to Takeda’s BLA for dengue vaccine candidate
Pharmaceutical Business Review
Sat, 11/26/22 - 07:18 pm
Takeda
FDA
TAK-003
vaccines
dengue
Biden forges new $475M campaign to drive uptake of Pfizer and Moderna's bivalent Covid vaccines
Endpoints
Tue, 11/22/22 - 04:25 pm
COVID-19
vaccines
boosters
bivalent boosters
Joe Biden
Pfizer
Moderna Therapeutics
NW Bio reports positive top-line results from phase 3 glioblastoma trial
Labiotech.eu
Mon, 11/21/22 - 07:23 pm
Northwest Biotherapeutics
DCVax
clinical trials
glioblastoma
brain cancer
vaccines
Overcoming the challenges of developing vaccines in an accelerated timeframe
Pharmaphorum
Mon, 11/21/22 - 09:57 am
vaccines
drug devlopment
COVID-19
Novavax Nuvaxovid COVID-19 Vaccine Receives Expanded Authorization in Canada as a Booster in Adults
BioSpace
Sun, 11/20/22 - 12:53 pm
Novavax
vaccines
COVID-19
Canada
Nuvaxovid
'I would put us up against mRNA': Novavax sets out vision for vaccine success in COVID and beyond
Fierce Biotech
Fri, 11/18/22 - 11:45 am
Novavax
Pfizer
Moderna Therapeutics
vaccines
COVID-19
Pfizer, BioNTech start study testing next COVID-19 vaccine
BioPharma Dive
Thu, 11/17/22 - 11:25 pm
Pfizer
BioNTech
vaccines
COVID-19
clinical trials
Emergent scores a DoD award to evaluate its chikungunya vaccine in the field
Endpoints
Thu, 11/17/22 - 12:12 pm
Emergent BioSolutions
chikungunya virus
Department of Defense
government contracts
vaccines
Curevo Vaccine announces closing of $26m Series A1 round
Pharmaceutical Business Review
Thu, 11/17/22 - 10:34 am
Curevo Vaccine
funding
vaccines
CRV-101
shingles
CureVac rethinks lead cancer program after posting PD-1 data, limiting future studies to mRNA vaccine combos
Fierce Biotech
Wed, 11/16/22 - 10:35 am
CureVac
vaccines
CV8102
MRNA
cancer
Daiichi Sankyo’s Covid-19 vaccine trial meets primary endpoint
Clinical Trials Arena
Tue, 11/15/22 - 10:51 am
Daiichi Sankyo
clinical trials
MRNA
vaccines
DS-5670
COVID-19
Moderna touts 'superior' antibody levels against Omicron for authorized Covid-19 bivalent booster
Endpoints
Mon, 11/14/22 - 07:14 pm
Moderna Therapeutics
boosters
bivalent boosters
vaccines
COVID-19
Sanofi, GSK crash the COVID-19 vaccine party late with a world-first nod for their next-gen booster
Fierce Pharma
Thu, 11/10/22 - 10:22 pm
Sanofi
GSK
COVID-19
Europe
vaccines
boosters
AstraZeneca withdraws US COVID vaccine application, shifts focus to antibody treatments
Fierce Pharma
Thu, 11/10/22 - 10:37 am
AstraZeneca
vaccines
COVID-19
Moderna’s Spikevax has higher risk of heart inflammation than Pfizer’s Comirnaty: Study
Medical Marketing and Media
Tue, 11/8/22 - 10:28 pm
Pfizer
Moderna Therapeutics
vaccines
COVID-19
myocarditis
Blue Lake reports positive data from Phase I RSV vaccine trial
Clinical Trials Arena
Tue, 11/8/22 - 11:08 am
Blue Lake Biotechnology
clinical trials
vaccines
BLB201
RSV
Novavax BA.1 booster data support COVID-19 vaccine strain switch, but bivalent fails to bring benefits
Fierce Biotech
Tue, 11/8/22 - 11:02 am
Novavax
COVID-19
vaccines
clinical trials
boosters
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
Endpoints
Fri, 11/4/22 - 10:21 am
Sanofi
AstraZeneca
RSV
nirsevimab
Europe
vaccines
Pages
« first
‹ previous
…
15
16
17
18
19
20
21
22
23
…
next ›
last »